PIPELINE
Progress
| Pipeline | Treatment Areas | Indication |
Initial
Development Clinical Trial Phase 1 Clinical Trial Phase 2 Clinical Trial Phase 3 |
|
|---|---|---|---|---|
|
RGN-259
|
Ophthalmic Disease
|
Dry Eye Disease
|
|
|
| Rare Diseases | Neurotrophic Keratopathy |
|
||
| OKN-007 | Brain Cancer | Glioblastoma Multiforme (nGBM) |
|
|
| Glioblastoma Multiforme (rGBM) |
|
|||
- DED (Dry Eye Disease) : ARISE (A Phase III Study of RGN-259 Identifying Safety and Efficacy)
- NK (Neurotrophic Keratopathy) : SEER (Safety and Efficacy Examination of RGN-259)